Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 124
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ann Ig ; 33(6): 589-601, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33779673

RESUMEN

Results: The results highlighted that 40 laboratories fall into the "low risk" and the remaining 2 into the "moderate risk" category. Conclusions: Labs with risk factors are a minority. These were properly identified using the proposed methodology. Background and aim: Biomedical research in academic settings is an important issue for Public Health and Environment protection. As workplaces, the facilities for research expose their personnel to different hazards and health risks. The University of L'Aquila (Italy) carried out a field study aimed at creating and applying a checklist intended for laboratory staff. Methods: The proposed checklist was derived from the procedure illustrated in the Appendix (procedure followed for the identification of a numerical index of biological risk for university facilities) and consists of 9 items. The study was conducted in 42 laboratories.


Asunto(s)
Lista de Verificación , Laboratorios , Humanos , Medición de Riesgo , Universidades , Lugar de Trabajo
2.
Eur J Paediatr Dent ; 25(1): 6-10, 2024 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-38353521

RESUMEN

BACKGROUND: The term hypomineralisation of molars and incisors (MIH), introduced in 2001 by Weerheijm et al., describes a clinical state of hypomineralisation of permanent molars with frequent involvement of the incisors. MIH is considered a global dental problem with a prevalence ranging from 2.4% to 40.2% in the entire world paediatric population. The continuous increase in the prevalence of enamel anomalies, including MIH, indicates the need to define new intervention protocols based on the technological advances that are revolutionising paediatric dentistry. The use of ozone associated with the selective and minimally invasive excavation of the dental tissue combines the antibacterial properties of the gas with an ultra-conservative approach aimed at the maximum conservation of the dental tissue. The operative protocol described can be an important tool in the prevention and treatment of MIH. The aim of this work is to illustrate an operative clinical protocol based on the combined use of selective excavation and ozone for the treatment of carious lesions in paediatric patients with MIH.


Asunto(s)
Caries Dental , Hipoplasia del Esmalte Dental , Humanos , Niño , Hipoplasia del Esmalte Dental/epidemiología , Susceptibilidad a Caries Dentarias , Caries Dental/epidemiología , Diente Molar/patología , Incisivo/anomalías , Prevalencia
3.
Nat Genet ; 19(4): 395-8, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9697704

RESUMEN

Alteration of thyroid gland morphogenesis (thyroid dysgenesis) is a frequent human malformation. Among the one in three to four thousand newborns in which congenital hypothyroidism is detected, 80% have either an ectopic, small and sublingual thyroid, or have no thyroid tissue. Most of these cases appear sporadically, although a few cases of recurring familial thyroid dysgenesis have been described. The lack of evidence for hereditary thyroid dysgenesis may be due to the severity of the hypothyroid phenotype. Neonatal screening and early thyroid hormone therapy have eliminated most of the clinical consequences of hypothyroidism such that the heritability of this condition may become apparent in the near future. We have recently cloned cDNA encoding a forkhead domain-containing transcription factor, TTF-2, and have located the position of the gene, designated Titf2, to mouse chromosome 4 (ref. 3). Titf2 is expressed in the developing thyroid, in most of the foregut endoderm and in craniopharyngeal ectoderm, including Rathke's pouch. Expression of Titf2 in thyroid cell precursors is down-regulated as they cease migration, suggesting that this factor is involved in the process of thyroid gland morphogenesis. Here we show that Titf2-null mutant mice exhibit cleft palate and either a sublingual or completely absent thyroid gland. Thus, mutation of Titf2-/- results in neonatal hypothyroidism that shows similarity to thyroid dysgenesis in humans.


Asunto(s)
Fisura del Paladar/embriología , Proteínas de Unión al ADN/fisiología , Modelos Animales de Enfermedad , Proteínas Represoras/fisiología , Glándula Tiroides/embriología , Factores de Transcripción/fisiología , Animales , Fisura del Paladar/genética , Proteínas de Unión al ADN/genética , Endodermo , Factores de Transcripción Forkhead , Hipotiroidismo/genética , Ratones , Ratones Noqueados , Morfogénesis , Proteínas Represoras/genética , Glándula Tiroides/patología , Factores de Transcripción/genética
4.
Eur Rev Med Pharmacol Sci ; 27(9): 4169-4174, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37203843

RESUMEN

BACKGROUND: Angiosarcoma (AS) of the breast is very rare, accounting for 1% of all soft tissue breast tumors. AS may present as primary tumors of the breast or as secondary lesions usually associated with previous radiotherapy. Commonly, secondary AS affects older women (median age 67-71 years) with a clinical history of breast cancer. The preferred site of onset of RIAS is the edge of radiation fields, where radiation doses and tumor necrosis may be heterogeneous, resulting in a DNA damage and instability. Radical surgery is the treatment of choice, but no clear consensus exists on surgical management of breast AS. CASE REPORT: We describe an atypical case of relapsed RIAS after radical mastectomy, treated with new surgery and, considering the higher risk of recurrence, subsequent adjuvant chemotherapy with weekly paclitaxel. CONCLUSIONS: The frequency of radiation-induced angiosarcomas (RIAS) after breast-conserving surgery and radiotherapy has been increased to 0.14-0.5% among long survivors. Nevertheless, even if RIAS continues to be prognostically an extremely unfavorable cancer due to a high rate of recurrence, distant spread, and median overall survival (OS) of about 60 months, the benefits of loco-regional breast radiotherapy are clearly higher than the risk in developing angiosarcoma.


Asunto(s)
Neoplasias de la Mama , Hemangiosarcoma , Neoplasias Inducidas por Radiación , Femenino , Humanos , Anciano , Neoplasias de la Mama/patología , Hemangiosarcoma/etiología , Hemangiosarcoma/terapia , Hemangiosarcoma/patología , Mastectomía/efectos adversos , Terapia Combinada , Neoplasias Inducidas por Radiación/diagnóstico , Neoplasias Inducidas por Radiación/terapia , Neoplasias Inducidas por Radiación/complicaciones , Radioterapia Adyuvante/efectos adversos
5.
Eur Rev Med Pharmacol Sci ; 26(14): 5008-5013, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35916797

RESUMEN

BACKGROUND: Glioblastoma (GBM) is a highly lethal disease despite integrated treatment comprising radiotherapy plus concomitant and adjuvant temozolomide, with a median overall survival of less than 15 months. For recurrent glioblastoma, there is yet no standard therapy, considering that Bevacizumab have failed to improve overall survival (OS) while regorafenib had a little benefit over standard chemotherapy. In addition, the disease control rate is almost exclusively stability, with a poor objective response rate. CASE REPORT: Here we present a case of rapid response to regorafenib in early glioblastoma progression at the end of adjuvant radiotherapy: after a single cycle of regorafenib the patient observed an impressive improvement in clinical condition, disappearance of headaches and a clear reduction of neoplastic tissue in MRI. A brief review about new radiological patterns in Magnetic Resonance Imaging (MRI) related to the introduction in clinical practice of antiangiogenic drugs and tyrosine kinase inhibitors has also been carried out. CONCLUSIONS: Regorafenib was certainly a first turning point in the second-line treatment of GBM, showing longer response rates and mostly disease stability than bevacizumab. A switch-maintenance strategy with tyrosine kinase inhibitors may represent a valid second-line therapeutic option.


Asunto(s)
Neoplasias Encefálicas , Glioblastoma , Bevacizumab/uso terapéutico , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/tratamiento farmacológico , Glioblastoma/diagnóstico por imagen , Glioblastoma/tratamiento farmacológico , Humanos , Recurrencia Local de Neoplasia/tratamiento farmacológico , Compuestos de Fenilurea , Inhibidores de Proteínas Quinasas/uso terapéutico , Piridinas
6.
Ann Ig ; 23(4): 337-46, 2011.
Artículo en Italiano | MEDLINE | ID: mdl-22026237

RESUMEN

Sexually transmitted human papillomaviruses (HPVs) are responsible for anogenital infections and tumours. Types 16 and 18 cause 70% of cervical carcinomas, the incidence of which is higher among young women. The aim of this study was to evaluate the propensity of mothers to have their 12-year-old daughters vaccinated against HPV and identify the variables that may influence their agreement, such as their kowledge of HPV and its relationship with cervical cancer. A 17-item questionnaire was anonymously administered to 312 mothers of girls born in 1997 who were invited to undergo vaccination by their local health authority. The results were analysed using the chi-squared test and STATA 9 statistical software. The analysis showed that 69% of the mothers had had their daughters vaccinated, that most of them know about HPV but only 20% clearly understood the relationship between HPV and cancer Acceptance of the vaccination seems to be associated more with a general predisposition to vaccinate than with a knowledge of HPV and its causal relationship with cervical carcinoma. This indicates a need for educational/ information programmes before and during the vaccination cycle.


Asunto(s)
Conocimientos, Actitudes y Práctica en Salud , Madres , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus , Neoplasias del Cuello Uterino/prevención & control , Adulto , Niño , Femenino , Humanos , Cooperación del Paciente , Encuestas y Cuestionarios
7.
Ann Ig ; 22(6): 499-511, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21417168

RESUMEN

Obesity is a prevalent health disease among the elderly as it contributes to the early onset of chronic morbidity and functional impairment and is also related to premature mortality. The prevalence of sarcopenic-obesity increases too with age in each sex leading to a significantly higher prevalence of physical impairment and disability, as well as higher prevalence of metabolic syndrome. We observe a natural phenomenon (ageing) and a complex world-wide illness (obesity) that should not be merely treated as the sum of the treatments for the elderly and for the obese. The balance between the potential benefits of treatment interventions, reducing premature morbidity and mortality, and the impact on quality of life in old age may be different from young and adult age in case of obesity and need to be seriously considered.


Asunto(s)
Envejecimiento , Síndrome Metabólico/etiología , Obesidad , Calidad de Vida , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Femenino , Humanos , Comunicación Interdisciplinaria , Italia/epidemiología , Masculino , Síndrome Metabólico/epidemiología , Síndrome Metabólico/prevención & control , Obesidad/complicaciones , Obesidad/epidemiología , Obesidad/etiología , Obesidad/fisiopatología , Obesidad/terapia , Prevalencia , Factores de Riesgo , Sarcopenia/etiología
8.
Cephalalgia ; 29(12): 1277-84, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19438917

RESUMEN

Medication overuse headache (MOH) is a challenging, debilitating disorder that develops from the frequent use of medications taken for the treatment of migraine headache pain. MOH affects an estimated 3-5% of the general population. The mechanisms underlying the development of MOH remain unknown. Opiates are one of the major classes of medications used for the treatment of migraine at least in some countries, including the USA. Although the effects of repeated opiate use for headache are unknown, it is possible that opiate use may contribute to increased frequency and occurrence of such headaches. Recent preclinical studies exploring the neuroadaptive changes following sustained exposure to morphine may give some insights into possible causes of MOH. Peripherally, these changes include increased expression of calcitonin gene-related peptide (CGRP) in trigeminal primary afferent neurons. Centrally, they include increased excitatory neurotransmission at the level of the dorsal horn and nucleus caudalis. Critically, these neuroadaptive changes persist for long periods of time and the evoked release of CGRP is enhanced following morphine pretreatment. Stimuli known to elicit migraine, such as nitric oxide donors or stress, produce hyperalgesia in morphine- but not in saline-pretreated rats even long after the discontinuation of the opiate. CGRP plays a prominent role in initiating vasodilation of the intracranial blood vessels and subsequent headache. Furthermore, studies have demonstrated increased excitability of the nociceptive pathway in migraine sufferers, and CGRP receptor antagonists have been shown to be efficacious in migraine pain. Thus, such persistent neuroadaptive changes may be relevant to the processes that promote MOH.


Asunto(s)
Analgésicos Opioides/efectos adversos , Cefaleas Secundarias/fisiopatología , Trastornos Migrañosos/tratamiento farmacológico , Morfina/efectos adversos , Nociceptores/efectos de los fármacos , Nervio Trigémino/efectos de los fármacos , Adaptación Fisiológica/efectos de los fármacos , Animales , Péptido Relacionado con Gen de Calcitonina/fisiología , Humanos , Hiperalgesia/inducido químicamente , Hiperalgesia/fisiopatología , Nociceptores/fisiología , Ratas , Nervio Trigémino/fisiología
9.
Eat Weight Disord ; 14(1): 23-32, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19367137

RESUMEN

UNLABELLED: Obesity, associated with morbidity and mortality, is a complex disorder, characterised by an increase in fat mass (FM). Most authors agree in considering essential an integrated treatment made up of nutritional intervention, physical reconditioning programme and cognitive-behavioural psychotherapy. However, the feasibility is problematic and data in literature confirming the validity of this approach are poor. AIM: To verify the efficacy of a multidimensional approach (Nutritional Psycho-Physical Reconditioning - NPPR) in obesity treatment. METHODS: All patients admitted from June 2002 to June 2004 (464 subjects) ranged from 18 to 65 years old, with a body mass index (BMI) >30 kg/m2 were included in the programme. After the nutritional status evaluation a standard dietetic treatment (group N) or an integrated and multidisciplinary obesity treatment (group NPPR) was proposed. RESULTS: In group NPPR treatment duration was significantly higher (142.6+/-26 vs 48.6+/-55 days - p=0.000), while the drop-out amount was definitely lower (5.5 vs 54.4%; p=0.000). Weight loss compared to the initial weight and the difference between initial and final FM resulted significantly higher in group NNPR. Subjects in NPPR obtained a higher increase in the distance covered in a 6-minute walk test (59.9+/-19 vs 40.5+/-17 m; p=0.04) and in muscular strength. State and trait anxiety, mood and quality of life scores improved in NPPR subjects while remained substantially stable in group N. CONCLUSIONS: An integrated approach to obesity is the way to be pursued in order to obtain important and at least short-term results.


Asunto(s)
Fármacos Antiobesidad/uso terapéutico , Terapia Cognitivo-Conductual , Dieta Reductora , Comunicación Interdisciplinaria , Obesidad/terapia , Grupo de Atención al Paciente , Adulto , Anciano , Índice de Masa Corporal , Prestación Integrada de Atención de Salud , Femenino , Humanos , Masculino , Persona de Mediana Edad , Necesidades Nutricionales , Estado Nutricional , Valor Nutritivo , Obesidad/dietoterapia , Obesidad/tratamiento farmacológico , Obesidad/psicología , Resultado del Tratamiento , Pérdida de Peso , Adulto Joven
10.
Curr Opin Genet Dev ; 9(3): 289-94, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10377281

RESUMEN

Congenital thyroid gland defects - resulting in reduced production of the hormones triiodothyronine (T3) and thyroxine (T4) - can be a consequence of either reduced or absent thyroid tissue (thyroid dysgenesis) or, less frequently, of impairment in the biochemical mechanisms responsible for hormone biosynthesis (thyroid dyshormonogenesis). Recent studies have revealed how mutations in the genes encoding either transcription factors or the thyroid stimulating hormone receptor cause, in humans or in mouse models, thyroid dysgenesis. This demonstrates, for the first time, the heritability of this condition. New genes responsible for thyroid dyshormonogenesis have also been discovered.


Asunto(s)
Hipotiroidismo Congénito , Hipotiroidismo/genética , Animales , Humanos , Ratones , Glándula Tiroides/metabolismo , Glándula Tiroides/patología , Hormonas Tiroideas/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA